BCL-2 antisense (G3139) plus docetaxel for treatment of progressive androgen-independent prostate cancer Meeting Abstract
| Authors: | Morris, M. J.; Tong, W. P.; Cordon-Cardo, C.; Drobnjak, M.; Kelly, W. K.; Slovin, S. F.; Rosen, N.; Scher, H. I. |
| Abstract Title: | BCL-2 antisense (G3139) plus docetaxel for treatment of progressive androgen-independent prostate cancer |
| Meeting Title: | 11th European Cancer Conference (ECCO 11) |
| Keywords: | drug efficacy; drug dosage; meeting abstract; meeting poster |
| Journal Title: | European Journal of Cancer |
| Volume: | 37 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2001 Oct 21-25 |
| Meeting Location: | Lisbon, Portugal |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2001-04-01 |
| Start Page: | S218 |
| End Page: | S219 |
| Language: | English |
| ACCESSION: | BCI:BCI200200289121 |
| DOI: | 10.1016/s0959-8049(01)81293-4 |
| PROVIDER: | biosis |
| PUBMED: | 11727708 |
| Notes: | Meeting Abstract: 801 -- Source: Biosis |
Altmetric
Citation Impact
BMJ Impact Analytics
